Loxapine Acute agitation & Terminated 22/05/2013 No inhalation disturbed behaviours Appraisal associated with schizophrenia & bipolar disorder Canakinumab CAPS Terminated 24/04/2013 No Appraisal Methylnalrexone opioid-induced bowel Terminated 27/03/2013 No dysfunction in people Appraisal with advanced illness receiving palliative care Vinflunine TCCU Not 23/01/2013 No approved Fluocinolone Diabetic macular Not 23/01/2013 No implant oedema Approved Tadalafil Benign Prostatic Terminated 23/01/2013 No Hyperplasia Decitabine AML Not 12/12/2012 No approved Bevacizumab Adv/Metastatic TA263 Not 22/08/2012 No breast Ca 1st line approved Adalimumab Moderate-severe UC Not 27/06/2012 No (2nd line) Approved Lapatinib HER2 +ve metastatic Not 27/06/2012 No breast Ca approved Trastuzumab HER2 +ve metastatic Not 27/06/2012 No breast Ca approved Cabazitaxel Metastatic prostate Not 11/05/2012 No Ca approved Dasatinib CML 1st line Not 25/04/2012 No approved Eribulin Locally advanced or TA250 Not 03/04/2012 No metastatic breast approved cancer Bevacizumab Metastatic colorectal Not 25/01/2012 No Ca 2nd Line approved Cetuximab Metastatic colorectal Not 25/01/2012 No Ca (2nd line) approved
Loxapine inhalation Acute agitation & disturbed behaviours associated with schizophrenia & bipolar disorder Terminated Appraisal 22/05/2013 No Canakinumab CAPS Terminated Appraisal 24/04/2013 No Methylnalrexone opioid-induced bowel dysfunction in people with advanced illness receiving palliative care Terminated Appraisal 27/03/2013 No Vinflunine TCCU Not approved 23/01/2013 No Fluocinolone implant Diabetic macular oedema Not Approved 23/01/2013 No Tadalafil Benign Prostatic Hyperplasia Terminated 23/01/2013 No Decitabine AML Not approved 12/12/2012 No Bevacizumab Adv/Metastatic breast Ca 1st line TA263 Not approved 22/08/2012 No Adalimumab Moderate-severe UC (2nd line) Not Approved 27/06/2012 No Lapatinib HER2 +ve metastatic breast Ca Not approved 27/06/2012 No Trastuzumab HER2 +ve metastatic breast Ca Not approved 27/06/2012 No Cabazitaxel Metastatic prostate Ca Not approved 11/05/2012 No Dasatinib CML 1st line Not approved 25/04/2012 No Eribulin Locally advanced or metastatic breast cancer TA250 Not approved 03/04/2012 No Bevacizumab Metastatic colorectal Ca 2nd Line Not approved 25/01/2012 No Cetuximab Metastatic colorectal Ca (2nd line) Not approved 25/01/2012 No